Kadalraja Raghavan

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Suryaprakash Vaddi et al. · Biomedicine & Pharmacotherapy · 2021 · 37 citations · Full text

Benefits of Gut Microbiota Reconstitution by Beta 1,3–1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases

Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Naoki Yamamoto et al. · Journal of Alzheimer s Disease · 2022 · 37 citations · Full text

Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study

Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki et al. · BMJ Neurology Open · 2022 · 28 citations · Full text

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease

Senthilkumar Preethy, Nobunao Ikewaki, Gary Levy et al. · BMJ Open Gastroenterology · 2022 · 22 citations · Full text

Improvement of sleep and melatonin in children with autism spectrum disorder after β‐1,3/1,6‐glucan consumption: An open‐label prospective pilot clinical study

Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Ramesh Shankar Kandaswamy et al. · Brain and Behavior · 2022 · 16 citations · Full text